Overview

To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions

Status:
Completed

Trial end date:
2005-09-01

Target enrollment:

Participant gender:

Summary

To demonstrate the relative bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg imipramine hydrochloride tablets in healthy adult volunteers under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Imipramine